The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease
Our study corroborates USP8 mutational status in combination with postsurgical MSC or 1-mg DST as independent predictors of long-term remission, highlighting their potential role in stratifying patients at risk for suboptimal outcomes.
Authors
- Tingwei Su
- Wenzhong Zhou (ORCID: https://orcid.org/0000-0002-1359-2784)
- Sichang Zheng
- Lei Jiang (ORCID: https://orcid.org/0000-0003-3831-9044)
- Yiran Jiang
- Lei Ye (ORCID: https://orcid.org/0000-0003-4064-4460)
- Weiqing Wang (ORCID: https://orcid.org/0000-0001-6027-3084)
- Xu Zhong (ORCID: https://orcid.org/0000-0002-2175-3437)
- Luming Wu
- Weiwei Zhou (ORCID: https://orcid.org/0000-0003-2003-7743)
- Jing Xie (ORCID: https://orcid.org/0000-0001-6825-0178)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1210/clinem/dgaf269
- Citations
- 3
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Chinese Society of Endocrinology
- National Natural Science Foundation of China
- Shanghai Health and Medical Development Foundation
- Shanghai Shenkang Hospital Development Center
- Shanghai Municipal Health and Family Planning Commission
- Science Technology on Reactor System Design Technology Laboratory, Nuclear Power Institute of China
- National Key Research and Development Program of China